tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Johnson & Johnson revises FY23 adjusted EPS view to $10.00-$10.10

Prior view was $10.70-$10.80. FY23 EPS consensus $10.75. Revises FY23 reported revenue view to $83.2B-$84B from $98.8B-$99.8B, consensus $100.23B. Guidance excludes Consumer Health.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See Insiders’ Hot Stocks on TipRanks >>

Read More on JNJ:

Disclaimer & DisclosureReport an Issue

1